Skip to main content
HYMPAVZI 75 mg/.5mL injection, solution by Pfizer Laboratories Div Pfizer Inc
HYMPAVZI, 75 mg/.5mL, injection, solution Available on prescription only. Listed by Pfizer Laboratories Div Pfizer Inc.
Prescription only

HYMPAVZI

marstacimab-hncq

Listed by Pfizer Laboratories Div Pfizer Inc

Strength
75 mg/.5mL
Form
Injection, Solution
Route
Subcutaneous

What it contains

  • Marstacimab 75 mg/.5mL

FDA record

Dosage form Injection, Solution
Route Subcutaneous
Approval route BLA — biologic licence
NDC code 0069-0775
FDA application BLA761369
RxNorm concept 2697139
Package sizes listed 1
Marketed since June 2026

Other products containing Marstacimab

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

HYMPAVZI

marstacimab-hncq

Strength
150 mg/mL
Form
Injection, Solution
Rx only

Pfizer Laboratories Div Pfizer Inc

Not stocked by us — reference only

HYMPAVZI

marstacimab-hncq

Strength
150 mg/mL
Form
Injection, Solution
Rx only

Pfizer Laboratories Div Pfizer Inc

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.